The Effect of Short‐Term Periodic Fasting on the Acetaminophen-Induced Liver Injury in Mice

Document Type : Research Paper


1 Department of Microbiology and Virology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

2 Antimicrobial Resistance Research Center, Bu-Ali Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran

3 Department of Physiology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

4 Department of Pathology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

5 Student Research Committee, Department of Epidemiology and Biostatistics, School of Health, Mashhad University of Medical Sciences, Mashhad, Iran


Introduction: In many cultures fasting is recommended as a way to protect and promote health. However, there are few studies on the effects of fasting on organ function and resistance to toxic agents such as drugs. This study was conducted to investigate the effect of short-term periodic fasting on the acetaminophen hepatotoxic effects in mice. Methods: In this experimental study, BALB/c female mice were used to investigate the effect of short-term periodic fasting (3 consecutive days, every 2 weeks for ten weeks) on serum aminotransferases (AST and ALT) level and hepatotoxic effects induced by acetaminophen. After ten weeks of periodic fasting, 500 mg/kg acetaminophen was injected intraperitoneally to mice. 24 hours later, AST and ALT levels were measured and then the mice were sacrificed to evaluate their liver injury severity using the pathological method as the gold standard. Results: Our results showed that AST and ALT enzymes increased in the control groupof mice (P = 0.0098 & P = 0.0004, respectively (Mann-Whitney test)) which was associated with high-grade liver injury (P = 0.001 (Fishers Exact test)). In contrast, the fasting group of mice showed slight changes in the amount of AST and ALT enzymes associated with low-grade liver injury. Conclusion: Acetaminophen is a common cause of drug-induced liver injury (DILI). Our findings in the current study showed that fasting can protect important organs such as the liver against the toxic effects of drugs. This study in mice could provide insight into human states.


1. Mattson MP, Longo VD, Harvie M. Impact of intermittent fasting on health and disease processes. Ageing research reviews. 2017;39:46-58.
2. Longo VD, Mattson MP. Fasting: molecular mechanisms and clinical applications. Cell metabolism. 2014;19(2):181-92.
3. Brandhorst S, Choi IY, Wei M, Cheng CW, Sedrakyan S, Navarrete G, et al. A periodic diet that mimics fasting promotes multi-system regeneration, enhanced cognitive performance, and healthspan. Cell metabolism. 2015;22(1):86-99.
4. Raffaghello L, Lee C, Safdie FM, Wei M, Madia F, Bianchi G, et al. Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy. Proceedings of the National Academy of Sciences. 2008;105(24):8215-20.
5. Verweij M, van Ginhoven TM, Mitchell JR, Sluiter W, van den Engel S, Roest HP, et al. Preoperative fasting protects mice against hepatic ischemia/reperfusion injury: mechanisms and effects on liver regeneration. Liver transplantation. 2011;17(6):695-704.
6. Apte UM, Limaye PB, Desaiah D, Bucci TJ, Warbritton A, Mehendale HM. Mechanisms of increased liver tissue repair and survival in diet-restricted rats treated with equitoxic doses of thioacetamide. Toxicological Sciences. 2003;72(2):272-82.
7. Aidoo A, Desai VG, Lyn-Cook LE, Chen JJ, Feuers RJ, Casciano DA. Attenuation of bleomycin-induced Hprt mutant frequency in female and male rats by calorie restriction. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 1999;430(1):155-63.
8. Bessems JG, Vermeulen NP. Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches. Critical reviews in toxicology. 2001;31(1):55-138.
9. James LP, Mayeux PR, Hinson JA. Acetaminophen-induced hepatotoxicity. Drug metabolism and disposition. 2003;31(12):1499-506.
10. Lee WM. Acetaminophen and the US Acute Liver Failure Study Group: lowering the risks of hepatic failure. Hepatology. 2004;40(1):6-9.
11. Mak A, Johnston A, Uetrecht J. Effects of immunization and checkpoint inhibition on amodiaquine-induced liver injury. Journal of immunotoxicology. 2017;14(1):89-94.
12. Rowden AK, Norvell J, Eldridge DL, Kirk MA. Updates on acetaminophen toxicity. Medical Clinics. 2005;89(6):1145-59.
13. Mitchell J, Jollow D, Potter W, Davis D, Gillette J, Brodie B. Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. Journal of Pharmacology and Experimental Therapeutics. 1973;187(1):185-94.
14. Heard K, Green JL, Anderson V, Bucher-Bartelson B, Dart RC. A randomized, placebo-controlled trial to determine the course of aminotransferase elevation during prolonged acetaminophen administration. BMC Pharmacology and Toxicology. 2014;15(1):39.
15. Jaeschke H, Xie Y, McGill MR. Acetaminophen-induced liver injury: from animal models to humans. Journal of clinical and translational hepatology. 2014;2(3):153.
16. Harper JM, Salmon AB, Chang Y, Bonkowski M, Bartke A, Miller RA. Stress resistance and aging: influence of genes and nutrition. Mechanisms of ageing and development. 2006;127(8):687-94.
17. Laskin DL, Laskin JD. Role of macrophages and inflammatory mediators in chemically induced toxicity. Toxicology. 2001;160(1-3):111-8.
18. Tolson JK, Dix DJ, Voellmy RW, Roberts SM. Increased hepatotoxicity of acetaminophen in Hsp70i knockout mice. Toxicology and applied pharmacology. 2006;210(1-2):157-62.
19. Shankar K, Vaidya VS, Corton JC, Bucci TJ, Liu J, Waalkes MP, et al. Activation of PPAR-α in streptozotocin-induced diabetes is essential for resistance against acetaminophen toxicity. The FASEB Journal. 2003;17(12):1748-50.
20. Oz HS, McClain CJ, Nagasawa HT, Ray MB, de Villiers WJ, Chen TS. Diverse antioxidants protect against acetaminophen hepatotoxicity. Journal of biochemical and molecular toxicology. 2005;18(6):361-8.
21. Galluzzi L, Baehrecke EH, Ballabio A, Boya P, Bravo‐San Pedro JM, Cecconi F, et al. Molecular definitions of autophagy and related processes. The EMBO journal. 2017;36(13):1811-36.
22. Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell. 2011;147(4):728-41.
23. Kaur J, Debnath J. Autophagy at the crossroads of catabolism and anabolism. Nature reviews Molecular cell biology. 2015;16(8):461.
24. Kroemer G, Mariño G, Levine B. Autophagy and the integrated stress response. Molecular cell. 2010;40(2):280-93.
25. Mizushima N, Yamamoto A, Matsui M, Yoshimori T, Ohsumi Y. In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Molecular biology of the cell. 2004;15(3):1101-11.
26. Du K, Farhood A, Jaeschke H. Mitochondria-targeted antioxidant Mito-Tempo protects against acetaminophen hepatotoxicity. Archives of toxicology. 2017;91(2):761-73.
27. Jarsiah P, Nosrati A, Alizadeh A, Hashemi-Soteh SMB. Hepatotoxicity and ALT/AST enzymes activities change in therapeutic and toxic doses consumption of acetaminophen in rats. International Biological and Biomedical Journal. 2017;3(3):119-24.
28. Shon Y-H, Nam K-S. Protective effect of Moutan Cortex extract on acetaminophen-induced hepatotoxicity in mice. Journal of ethnopharmacology. 2004;90(2-3):415-9.
29. Jenniskens FA, Jopperi-Davis KS, Walters LC, Schorr EN, Rogers LK, Welty SE, et al. Effects of fasting on tissue contents of coenzyme A and related intermediates in rats. Pediatric research. 2002;52(3):437-42.
30. Tsuchiya T, Higami Y, Komatsu T, Tanaka K, Honda S, Yamaza H, et al. Acute stress response in calorie-restricted rats to lipopolysaccharide-induced inflammation. Mechanisms of ageing and Development. 2005;126(5):568-79.
31. Yu BP, Chung HY. Stress resistance by caloric restriction for longevity. Annals of the New York Academy of Sciences. 2001;928(1):39-47.